Cornell researchers have discovered a way to open one of the major barriers to the brain, called the blood brain barrier (BBB), which prevents the entry of therapies to treat brain disorders, such as Alzheimer’s disease.
The finding also has implications for treating all chemotherapy-resistant cancers.
For a century now, a major challenge in the treatment of diseases of the brain has been discovering how to safely deliver drugs across the BBB. The BBB is composed of a layer of specialized cells, called endothelial cells, which line the brain’s blood vessels and safeguard the brain from unwanted substances. These cells also selectively allow entry of molecules needed for brain function, such as amino acids, oxygen, glucose and water.
Cornell researchers report that an FDA-approved drug called Lexiscan, which is used in heart imaging, activates receptors – called adenosine receptors – that are expressed on these BBB cells.
“We can open the BBB for a brief window of time, long enough to deliver therapies to the brain, but not too long so as to harm the brain. We hope in the future, this will be used to treat many types of neurological disorders,” said Margaret Bynoe, associate professor in the Department of Microbiology and Immunology in Cornell’s College of Veterinary Medicine. Bynoe is senior author of the study appearing April 4 in The Journal of Clinical Investigation. Do-Geun Kim, now a postdoctoral associate in Bynoe’s lab, is the paper’s first author.
The researchers were able to deliver chemotherapy drugs into the brains of mice, as well as large molecules, like an antibody that binds to Alzheimer’s disease plaques, according to the paper.
To test whether this drug delivery system has application to the human BBB, the lab engineered a BBB model using human primary brain endothelial cells. They observed that Lexiscan opened the engineered BBB in a manner similar to its actions in mice.
Bynoe and Kim discovered that a protein called P-glycoprotein is highly expressed on brain endothelial cells and blocks the entry of most drugs delivered to the brain. Lexiscan acts on one of the adenosine receptors expressed on BBB endothelial cells specifically activating them. They showed that Lexiscan down-regulates P-glycoprotein expression and function on the BBB endothelial cells. It acts like a switch that can be turned on and off in a time dependent manner, which provides a measure of safety for the patient.
“We demonstrated that down-modulation of P-glycoprotein function coincides exquisitely with chemotherapeutic drug accumulation” in the brains of mice and across an engineered BBB using human endothelial cells, Bynoe said. “The amount of chemotherapeutic drugs that accumulated in the brain was significant.”
In addition to P-glycoprotein’s role in inhibiting foreign substances from penetrating the BBB, the protein is also expressed by many different types of cancers and makes these cancers resistant to chemotherapy.
“This finding has significant implications beyond modulation of the BBB,” Bynoe said. “It suggests that in the future, we may be able to modulate adenosine receptors to regulate P-glycoprotein in the treatment of cancer cells resistant to chemotherapy.”
Because Lexiscan is an FDA-approved drug, ”the potential for a breakthrough in drug delivery systems for diseases such as Alzheimer’s disease, Parkinson’s disease, autism, brain tumors and chemotherapy-resistant cancers is not far off,” Bynoe said.
Another advantage is that these molecules (adenosine receptors and P-glycoprotein are naturally expressed in mammals. “We don’t have to knock out a gene or insert one for a therapy to work,” Bynoe said.
Learn more: Breakthrough allows drug delivery for brain diseases, cancers
The Latest on: Blood brain barrier
[google_news title=”” keyword=”blood brain barrier” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Blood brain barrier
- RFK Jr. says a parasite ate part of his brain. Do parasites actually 'eat' human tissue?on May 10, 2024 at 9:51 am
Robert F. Kennedy Jr.'s campaign says a parasitic worm the presidential candidate contracted years ago while traveling outside of the United States ate a portion of his brain, then died.
- How ultrasound and microbubbles could deliver immunotherapy to the brainon May 9, 2024 at 10:44 am
Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. Treatments are limited by the blood–brain barrier, a unique ...
- Nanobiotechnology-Based Strategies for Crossing the Blood–Brain Barrieron May 7, 2024 at 5:00 pm
No writing assistance was utilized in the production of this manuscript. The blood–brain barrier (BBB) is a significant obstacle to therapeutic delivery for CNS disorders. Among various ...
- Nanoparticle Breaks through Blood-Brain Barrier to Target Brain Metastaseson May 6, 2024 at 4:01 pm
Nanoparticle that penetrates the blood-brain barrier can shrink breast and brain tumors in laboratory studies.
- Researchers develop a nanoparticle that can penetrate the blood-brain barrieron May 6, 2024 at 12:00 pm
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to ...
- Sylvester researchers develop a nanoparticle that can penetrate the blood-brain barrieron May 5, 2024 at 5:00 pm
Researchers at Sylvester Comprehensive Cancer Center have developed a nanoparticle that can penetrate the blood-brain barrier. Their goal is to kill primary breast cancer tumors and brain metastases ...
- New Hope for Neurological Disorders: Scientists Have Discovered How an Essential Nutrient Enters the Brainon May 3, 2024 at 9:33 pm
Researchers have discovered the process by which dietary choline crosses the blood-brain barrier. This breakthrough has potential applications in enhancing drug delivery to the brain for treating ...
- Research on how dietary choline travels through the blood-brain barrier reveals pathway for treating brain disorderson May 1, 2024 at 8:00 am
A University of Queensland researcher has found molecular doorways that could be used to help deliver drugs into the brain to treat neurological disorders.
- Modelling of the blood–brain barrier in drug discovery and developmenton April 30, 2024 at 5:00 pm
The blood–brain barrier (BBB) is implicated in pathologies such as neurodegenerative disorders, stroke and traumatic brain injury as well as in infectious processes and inflammatory pain.
- I’m a nutritionist – here are the best foods to eat for a healthy brainon April 26, 2024 at 11:03 pm
It is involved in nerve-signalling and is also known to preserve the integrity of the blood-brain barrier. “The blood-brain barrier is a network of blood vessels and tissues of closely spaced cells ...
via Bing News